Press release
Malignant Ascites Therapeutics Market Size in the 7MM was ~ USD 1990 Million in 2020, is expected to grow by 2034, and estimated DelveInsight
Discover Key Insights into the Malignant Ascites Market with DelveInsight's In-Depth Report @ [https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Malignant Ascites Market Report
* Among the 7MM, the United States accounted for the highest incident cases of Malignant ascites in 2020, with around 350,000 cases; these cases are expected to increase during the forecast period.
* Among all the associated cancers, the highest incident cases were reported in Breast Cancer. In 2020 the total incident cases of Breast Cancer were 640,000.
* In 2020, the total patient pool of Malignant Ascites were 390,000 in the EU4 and the UK.
* The leading Malignant Ascites Companies such as Clover Biopharmaceuticals, Wuhan YZY Biopharma Co., Ltd., Neovii Biotech, Jiangsu Simcere Pharmaceutical, Neovii Biotech, Sanofi , and others
* Promising Malignant Ascites Therapies such as SCB-313, M701, catumaxomab, Endostar, Catumaxomab, aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP Registered ), and others
Navigate the complexities of the Malignant Ascites Market: gain insights into drug trends, treatment scenarios, and epidemiological data through our insightful Malignant Ascites Market Forecast. Click here to get more insights @ Malignant Ascites Treatment Market [https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Malignant Ascites Epidemiology Segmentation in the 7MM
* Total Incident Cases of Ascites in Selected Indications (Ovarian, Colorectal, Gastric, and Others) in the 7MM
* Incident Cases of Malignant Ascites in Selected Indications in the 7MM
* Total Treated Cases of Malignant Ascites in the 7MM
Download the report to understand which factors are driving Malignant Ascites epidemiology trends @ Malignant Ascites Prevalence [https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Malignant ascites Emerging Drugs Profile
* Catumaxomab: Lindis Biotech
Catumaxomab is a bispecific trifunctional antibody that binds directly to the tumor cell with one of its binding sites. It activates two essential components of the immune system with the other binding sites: T cells and macrophages (scavenger cells). The antibody recognizes and binds to all EpCAM-positive tumor cells, including critical cancer stem cells and all CD3-positive T cells. The EpCAM marker is present on almost all carcinomas and is, therefore, a promising approach for targeted cancer treatment. As per company pipeline, catumaxomab is in the preregistration stage of development for the treatment of Malignant ascites.
* M 701: Wuhan YZY Biopharma
M701 is a new biological Class I drug that targets both EpCAM and CD3 being developed by YBODY Biotech through its independently patented asymmetric bispecific antibody YBODY Registered platform. The drug is mainly used for the treatment of malignant ascites (MA) and malignant pleural effusion (MPE) derived from EpCAM-positive cancer.M701 dual-antibody targets the EpCAM antigen on one end. At the same time, the CD3 antibody on the other end can bridge T cells and activate T cells to kill EpCAM-positive tumor cells. Currently, M701 is in the Phase II stage of development for the treatment of malignant ascites.
Malignant Ascites Drugs Market Insights
Antibody-dependent cell cytotoxicity
Antibody-Dependent Cellular Cytotoxicity (ADCC) is a crucial mechanism of the immune system involving the targeting and destruction of pathogenic cells by effector cells, particularly natural killer (NK) cells. ADCC is a process where specific antibodies bind to pathogens, marking them for destruction by NK cells through the injection of cytotoxic factors, leading to cell lysis. Antibodies recognize and bind to target cells, which are then attacked and destroyed by effector cells like NK cells. This process plays a vital role in immune responses against pathogens and cancer cells.
Get In-Depth Knowledge on Malignant Ascites Market Trends and Forecasts with DelveInsight @ Malignant Ascites Treatment Market [https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Malignant Ascites Therapies and Companies
* SCB-313: Clover Biopharmaceuticals
* M701: Wuhan YZY Biopharma Co., Ltd.
* catumaxomab: Neovii Biotech
* Endostar: Jiangsu Simcere Pharmaceutical
* Catumaxomab: Neovii Biotech
* aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP Registered ): Sanofi
Scope of the Malignant Ascites Market Report
* Study Period: 2020-2034
* Coverage: 7MM
* Malignant Ascites Companies: Clover Biopharmaceuticals, Wuhan YZY Biopharma Co., Ltd., Neovii Biotech, Jiangsu Simcere Pharmaceutical, Neovii Biotech, Sanofi, and others
* Malignant Ascites Therapies: SCB-313, M701, catumaxomab, Endostar, Catumaxomab, aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP Registered ), and others
* Malignant Ascites Therapeutic Assessment: Malignant Ascites current marketed and Malignant Ascites emerging therapies
* Malignant Ascites Market Dynamics: Malignant Ascites market drivers and Malignant Ascites market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Malignant Ascites Unmet Needs, KOL's views, Analyst's views, Malignant Ascites Market Access and Reimbursement
Gain a strategic edge in the Malignant Ascites Market: explore comprehensive drug insights, treatment updates, and epidemiological forecasts in our in-depth Malignant Ascites Market Forecast. Click here to lead in advancements @ Malignant Ascites Clinical Trials Assessment [https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
1. Malignant Ascites Market Report Introduction
2. Executive Summary for Malignant Ascites
3. SWOT analysis of Malignant Ascites
4. Malignant Ascites Patient Share (%) Overview at a Glance
5. Malignant Ascites Market Overview at a Glance
6. Malignant Ascites Disease Background and Overview
7. Malignant Ascites Epidemiology and Patient Population
8. Country-Specific Patient Population of Malignant Ascites
9. Malignant Ascites Current Treatment and Medical Practices
10. Malignant Ascites Unmet Needs
11. Malignant Ascites Emerging Therapies
12. Malignant Ascites Market Outlook
13. Country-Wise Malignant Ascites Market Analysis (2020-2034)
14. Malignant Ascites Market Access and Reimbursement of Therapies
15. Malignant Ascites Market Drivers
16. Malignant Ascites Market Barriers
17. Malignant Ascites Appendix
18. Malignant Ascites Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=malignant-ascites-therapeutics-market-size-in-the-7mm-was-usd-1990-million-in-2020-is-expected-to-grow-by-2034-and-estimated-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Malignant Ascites Therapeutics Market Size in the 7MM was ~ USD 1990 Million in 2020, is expected to grow by 2034, and estimated DelveInsight here
News-ID: 3796162 • Views: …
More Releases from ABNewswire
How to Know When It's Time for an Exterminator: Evo Foam Pest Control's Expert G …
Not sure when to contact an exterminator? Evo Foam Pest Control explains the common signs of pest problems in Austin and why timely intervention is essential.
Austin, TX - Pest infestations can occur at any time, leaving homeowners in Austin, TX, wondering when it's necessary to call an exterminator Austin TX. With numerous pests, including ants, rodents, and termites, threatening the comfort of homes, it's essential to recognize the signs that…
Palm Coast Pest Control Shows How Eco-Friendly Pest Control Keeps Jupiter, FL Ho …
Discover how Palm Coast Pest Control uses eco-friendly solutions to protect Jupiter, FL homes from pests while maintaining a healthy, chemical-free environment.
Jupiter, FL - As residents of Jupiter, FL, seek effective and sustainable solutions to pest problems, Palm Coast Pest Control stands out as a trusted provider of eco-friendly pest control services. The company has earned a reputation for its commitment to keeping homes safe, healthy, and pest-free while also…
Metro Heat and Air OKC Stands Out for Expertise, Reliability, and Customer Care …
Metro Heat and Air OKC is known for delivering top-notch air conditioning services in Edmond, OK, combining professionalism, trustworthiness, and outstanding customer service.
Edmond, OK - In Edmond, OK, residents seeking reliable air conditioning services turn to Metro Heat and Air OKC, a trusted HVAC contractor [https://www.google.com/maps?cid=12790181814582558152] committed to delivering exceptional comfort solutions. The company has earned a solid reputation in the area for its high level of expertise, dependability, and…
Sugar Rush Lounge at I Dream of Sugar in Nassau, Bahamas Becomes a Destination f …
Sugar Rush Lounge in Nassau, Bahamas, delights dessert lovers with unique sweets, making it the go-to spot for indulgence and unforgettable treats.
Nassau, Bahamas - The Sugar Rush Lounge is quickly becoming a standout destination in the heart of Nassau, Bahamas. Known for its vibrant energy and inviting atmosphere, this unique dessert-focused lounge blends the indulgence of sweet treats with the stylish ambiance of a Nassau bar and lounge [https://idreamofsugar.com/srl-home/]. Designed…
More Releases for Malignant
Malignant Mesothelioma Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Malignant Mesothelioma Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Adult Malignant Glioma Therapeutics Market - Defying the Tumor, Empowering Survi …
Newark, New Castle, USA - new report, titled Adult Malignant Glioma Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Adult Malignant Glioma Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Adult Malignant Glioma Therapeutics market. The report offers…
Malignant Mesothelioma-Pipeline Review H2 2018
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Human Parainfluenza Virus 3 Infections-Pipeline Review, H2 2018, provides an overview of the Human Parainfluenza Virus 3 Infections (Infectious Disease) pipeline landscape.
Human parainfluenza virus 3 is a life-threatening infection that causes respiratory illnesses in infants and young children. Symptoms include fever, cough, runny nose, croup, bronchiolitis, wheezing and sore throat. Treatment includes over-the-counter medications for pain and fever.
Report Highlights
Publisher's Pharmaceutical…
Malignant Mesothelioma-Pipeline Review H2 2018
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Mesothelioma-Pipeline Review, H2 2018, provides an overview of the Malignant Mesothelioma (Oncology) pipeline landscape.
Malignant pleural mesothelioma is a rare cancer often diagnosed in people who have been exposed to high levels of asbestos. The malignancy affects the pleura, a thin membrane of lubricating cells that lines the lungs and chest wall. Peritoneal mesothelioma originates in the abdomen and as a result,…
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Malignant Melanoma
2. Malignant Melanoma Drug Mechanism of Action
3. Global Malignant Melanoma Market Analysis
3.1 Current Market Scenario
3.2 Global Malignant Melanoma Pipeline Overview
4. Global Malignant Melanoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges
5. Global Malignant Melanoma Drug Market Future Prospects
6. Global Malignant Melanoma Clinical Pipeline By…
Rising Number of People Diagnosed with Malignant Glioma Supports the Growth of t …
Glioma is a type of tumor that occurs in brain or spine. It is a group of brain tumor that includes oligodendrogliomas and astrocytomas. Gliomas include all types of brain tumors arising from supportive tissue of the brain. Malignant glioma is the most common type of brain tumor observed in adults globally. Collectively they contribute around 40% of the total cases diagnosed with brain tumor. In the last decade, there…
